Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Oric Pharmaceuticals Inc (NQ: ORIC )

4.490 -0.070 (-1.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 101,947
Open 4.510
Bid (Size) 4.480 (1)
Ask (Size) 4.500 (3)
Prev. Close 4.560
Today's Range 4.300 - 4.585
52wk Range 2.360 - 7.480
Shares Outstanding 45,091,215
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Updates
From ORIC Pharmaceuticals
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
 
Via Benzinga

Performance

YTD
-25.04%
-25.04%
1 Month
-5.07%
-5.07%
3 Month
+47.70%
+47.70%
6 Month
+26.84%
+26.84%
1 Year
-32.78%
-32.78%

More News

Read More
ORIC Pharmaceuticals Announces Multiple Presentations at the 2023 American Association for Cancer Research (AACR) Annual Meeting
From ORIC Pharmaceuticals
Via Globe NewsWire
ORIC Pharmaceuticals to Participate in the Oppenheimer 33rd Annual Healthcare Conference
From ORIC Pharmaceuticals
Via Globe NewsWire
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From ORIC Pharmaceuticals
Via Globe NewsWire
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
From ORIC Pharmaceuticals
Via Globe NewsWire
7 Top Short-Squeeze Candidates to Watch in February
Via InvestorPlace
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones
From ORIC Pharmaceuticals
Via Globe NewsWire
ORIC Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference
From ORIC Pharmaceuticals
Via Globe NewsWire
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
US Stocks Open Lower; Dow Falls Over 100 Points
Via Benzinga
Dow Dips 600 Points; AMC Entertainment Shares Plunge
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Nasdaq Down Over 3%; IsoPlexis Shares Spike Higher
Via Benzinga
Why AMC Entertainment Shares Are Trading Lower By Around 13%? Here Are 59 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
CENN Stock Alert: Cenntro Electric Receives EPA Certification
Via InvestorPlace
Dow Tumbles 300 Points; US Economy Expands 3.2% In Q3
Via Benzinga
ORIC Pharmaceuticals (ORIC) Stock Rockets 58% on Pfizer Deal
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
ORIC Pharmaceuticals Shares Move Higher After Equity Infusion, Clinical Collaboration From Pfizer
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why ORIC Pharmaceuticals Shares Are Trading Higher By Around 46%; Here Are 27 Stocks Moving Premarket
Via Benzinga
ORIC Pharmaceuticals Announces Clinical Development Collaboration with Pfizer for ORIC-533 in Multiple Myeloma and Concurrent $25 Million Equity Investment by Pfizer
From ORIC Pharmaceuticals
Via Globe NewsWire
ORIC Pharmaceuticals Presents Preclinical Data Demonstrating ORIC-533 as a Potential Best-in-Class CD73 Inhibitor at the 64th American Society of Hematology (ASH) Annual Meeting
From ORIC Pharmaceuticals
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.